PACS Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeWall Street coverage
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- 15.27
- PEG ratio
- 1.02
- P/B
- 5.48
- P/S (TTM)
- 0.98
- EV/EBITDA
- 22.96
Profitability & growth
- ROE (TTM)
- 23.0%
- Operating margin
- 7.0%
- Revenue growth YoY
- 12.4%
- Dividend yield
- —
- Beta
- 0.06
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About PACS Group, Inc.
Company profilePACS Group, Inc. is a prominent technology solutions provider dedicated to improving operational efficiency across diverse industries through innovative software and hardware systems. The company emphasizes research and development, positioning itself to leverage emerging technological trends and drive digital transformation. With robust strategic partnerships and a significant market presence, PACS Group is well-equipped to enhance its competitive advantage, making it an attractive investment opportunity for institutional investors seeking growth in the rapidly evolving technology landscape.
Classification
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 90 S. 400 W, SALT LAKE CITY, UT
- Fiscal year end
- December
- Latest quarter
- Dec 31, 2025
Educational content · Not investment advice or recommendations
We're educators, not advisors. Your decisions are your own. Disclaimer
I'm your AI thinking companion for the markets — I can help you explore and learn, but I'm not a financial advisor. Everything here is educational. Disclaimer